STAAR SURGICAL CO

STAA Net selling

CIK 0000718937 #2442 in the set updated 17 Sep 2026

Bought (120 mo)

$189.62M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$400.92M

$0.00 on a plan · $137.70M straight out of an exercise

Sold at will

$263.22M

94 of 164 sales

Net

−$211.30M

−$73.60M against sales at will

By person

28 insiders · 372 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BROADWOOD PARTNERS, L.P. entity

Director

$189.28M (166)

$245.60M (56)

−$56.32M

49,803,950

99.32%

$927.10M

+11.8%

Mason Caren L

President & CEO

—

$44.51M (13) scheduled

−$44.51M

152,415

0.3040%

$2.84M

+136.3%

Blickensdoerfer Hans-Martin

Sr. VP, Comm. Ops, China

—

$33.55M (18) scheduled

−$33.55M

83,110

0.1657%

$1.55M

−28.8%

Gesten Samuel J

Chief Legal Officer

—

$13.76M (8) scheduled

−$13.76M

43,665

0.0871%

$812.82K

+34.7%

Holliday Keith

Chief Technology Officer

—

$13.10M (19) scheduled

−$13.10M

28,157

0.0562%

$524.14K

−19.6%

Francese James E

Sr. VP, Comm. Ops., NA, APAC

—

$12.64M (13) scheduled

−$12.64M

42,660

0.0851%

$794.12K

+6.5%

Hayashida Jon K.

VP, Global Clinical, Medical

—

$10.72M (10) scheduled

−$10.72M

16,301

0.0325%

$303.44K

−23.6%

Moore John C

Director

—

$7.15M (1)

−$7.15M

2,117

0.0042%

$39.41K

−98.2%

SILVERMAN LOU

Director

—

$6.87M (4) scheduled

−$6.87M

12,658

0.0252%

$235.63K

−19.4%

Hansen Graydon C.

Sr. VP, Global Operations

—

$6.73M (11) scheduled

−$6.73M

9,801

0.0195%

$182.45K

−61.4%

ANDREWS DEBORAH J

Chief Financial Officer & EVP

—

$4.97M (7) scheduled

−$4.97M

38,910

0.0776%

$724.31K

—

Williams Patrick F.

Chief Financial Officer

—

$1.07M (2)

−$1.07M

56,242

0.1122%

$1.05M

—

Wall William P

Director

—

$206.75K (1)

−$206.75K

16,489

0.0329%

$306.94K

+37.1%

WEISNER AIMEE S

Director

$164.13K (2)

—

+$164.13K

15,352

0.0306%

$285.78K

—

Lin Elizabeth Yeu

Director

$100.00K (1)

—

+$100.00K

5,099

0.0102%

$94.92K

—

Barnes Scott D

Chief Medical Officer

—

$55.29K (1)

−$55.29K

41,502

0.0828%

$772.56K

+229.0%

Butcher Arthur C

Director

$49.96K (1)

—

+$49.96K

9,549

0.0190%

$177.75K

—

Zhou Lilian Yansheng

Director

$26.13K (1)

—

+$26.13K

8,101

0.0162%

$150.80K

—

Foust Warren

President and CEO

—

—

—

95,816

0.1911%

$1.78M

+2,384%

Jiang Wei

Director

—

—

—

77,127

0.1538%

$1.44M

—

FRINZI THOMAS G

President & CEO

—

—

—

70,519

0.1406%

$1.31M

—

Michna Magda

Chief Development Officer

—

—

—

41,343

0.0824%

$769.60K

—

FARRELL STEPHEN C

President & CEO

—

—

—

35,156

0.0701%

$654.43K

—

Studholme Robert

Senior VP, Operations

—

—

—

31,980

0.0638%

$595.31K

+49.4%

Brown Stephen P

VP, Chief Financial Officer

—

—

—

31,881

0.0636%

$593.46K

+42.0%

SISITSKY NATHANIEL

Chief Legal Officer

—

—

—

22,812

0.0455%

$424.65K

—

Kliman Gilbert H

Director

—

—

—

10,457

0.0209%

$194.66K

—

Yu K Peony

Director

—

—

—

2,786

0.0056%

$51.86K

—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 321

Amendments (4/A) skipped 5

Filings about a different issuer 0

Unreadable filings 0

Joint filings 44

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 70

Sales at will 94

Transactions with no price 0

Shares from compensation/vesting 3,426,585

Sales filed before the plan box existed 94

History held since 9 Dec 2016